EUVIMEDEUVIMED entdecken
Vergleichsstudie

A Nitric Oxide-Generating Beta-Blocking Agent Prevents Renal Injury in the Rat Remnant Kidney Model

Yoshihiro Takamitsu, Takeshi Nakanishi, Futoshi Nishihara, Yukiko Hasuike, Masaaki Izumi, Toru Inoue, Keisuke Hiraoka, Reiko Itahana, Koji Miyagawa

Nephron Physiology · 2003

DOI: 10.1159/000068529 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Nephron Physiology, 2003. Verfasst von Yoshihiro Takamitsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Kidney and Dialysis, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. y-tkmt@hyo-med.ac.jp. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The L-arginine-nitric oxide (NO) pathway plays an important role in the modulation of glomerular disease. We investigated whether β-blocking agents, with and without an NO-generating function, had renoprotective effects in the 5/6 nephrectomized rats (Nx), an animal model of glomerulosclerosis.

Methods

Nipradilol, a β-blocker with an ONO2 group (5, 10 or 15 mg/kg/day) and propranolol, a β-blocker without this group (50 mg/kg/day) were administered for 12 weeks to Nx together with and without nitro-L-arginine methyl ester (L-NAME). We evaluated the effects of both drugs on proteinuria, hypertension, renal function, glomerulosclerosis and urinary excretion of NO metabolites (UNOx) and cyclic GMP (UcGMP).

Results

Both drugs similarly attenuated the elevated blood pressure in Nx. However, nipradilol, at doses of 10 and 15 mg/kg/day, significantly decreased proteinuria and glomerulosclerosis, while propranolol did not. Nx showed reduced UNOx in comparison with the sham-operated rats. Nipradilol increased UNOx and UcGMP significantly and in a dose- dependent manner, whereas propranolol reduced them to levels lower than those in Nx. Nx receiving L-NAME reduced UNOx. The addition of nipradilol increased UNOx and decreased urinary protein excretion and glomerulosclerosis, suggesting that the NO released from the drug contributed to its renoprotective effect.

Conclusion

These findings indicate that nipradilol exerts its renoprotective effect through NO generation, and not by lowering blood pressure. The β-adrenergic blocking action per se does not seem to be related to the renoprotective effect of these agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsAnimalsCyclic GMPEnzyme InhibitorsHypertensionKidneyKidney DiseasesKidney GlomerulusMaleNG-Nitroarginine Methyl EsterNephrectomyNitratesNitric OxideNitric Oxide DonorsNitric Oxide SynthaseNitritesPropanolaminesPropranololProteinuriaRats

Substanzen

Adrenergic beta-AntagonistsEnzyme InhibitorsNitratesNitric Oxide DonorsNitritesPropanolaminesNitric OxidePropranololNitric Oxide SynthaseRenin

Autor:innen und Institutionen

  • Division of Kidney and Dialysis, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. y-tkmt@hyo-med.ac.jp

Zitieren

APA

Takamitsu, Y., Nakanishi, T., Nishihara, F., Hasuike, Y., Izumi, M., Inoue, T., Hiraoka, K., Itahana, R., & Miyagawa, K. (2003). A Nitric Oxide-Generating Beta-Blocking Agent Prevents Renal Injury in the Rat Remnant Kidney Model. Nephron Physiology. https://doi.org/10.1159/000068529

Vancouver

Takamitsu Y, Nakanishi T, Nishihara F, Hasuike Y, Izumi M, Inoue T, et al. A Nitric Oxide-Generating Beta-Blocking Agent Prevents Renal Injury in the Rat Remnant Kidney Model. Nephron Physiology. 2003. doi:10.1159/000068529

BibTeX
@article{Takamitsu2003,
  author = {Takamitsu, Yoshihiro and Nakanishi, Takeshi and Nishihara, Futoshi and Hasuike, Yukiko and Izumi, Masaaki and Inoue, Toru and Hiraoka, Keisuke and Itahana, Reiko and Miyagawa, Koji},
  title = {A Nitric Oxide-Generating Beta-Blocking Agent Prevents Renal Injury in the Rat Remnant Kidney Model},
  journal = {Nephron Physiology},
  year = {2003},
  doi = {10.1159/000068529}
}
Kostenlos starten →